SCHEMBL17879377

SCHEMBL17879377

CN(C)c1ccc(/C=C2\N=C(c3ccccc3)OC2=O)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLCG2 P16885 1/20 0.64
CSNK2A2 P19784 3/20 0.62
CSNK2B P67870 3/20 0.62
CSNK2A1 P68400 3/20 0.62
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
F2 P00734 1/20 0.61
F10 P00742 1/20 0.61
PLG P00747 1/20 0.61
PLAU P00749 1/20 0.61
PLAT P00750 1/20 0.61
KLKB1 P03952 1/20 0.61
DAPK3 O43293 1/20 0.58
NOTUM Q6P988 1/20 0.56
ALDH1A1 P00352 3/20 0.55
KDM4E B2RXH2 1/20 0.53
MAPT P10636 1/20 0.53
ALOX5 P09917 1/20 0.50
TNNI3 P19429 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6801976 1.00 PLCG2 (0.64) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1
SCHEMBL5973988 1.00 PLCG2 (0.64) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1
SCHEMBL11974092 0.88 PLCG2 (0.78) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1
SCHEMBL6790249 0.85 PLCG2 (0.60) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1
SCHEMBL6790252 0.85 PLCG2 (0.60) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1
SCHEMBL21090031 0.85 DAPK3 (0.57) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1
SCHEMBL6802450 0.85 CSNK2A2 (0.81) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1
SCHEMBL6802454 0.85 CSNK2A2 (0.81) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1
SCHEMBL2131623 0.85 DAPK3 (0.75) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1
SCHEMBL2131615 0.85 DAPK3 (0.75) PLCG2CSNK2A2CSNK2BCSNK2A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230209847-A1 ORGANIC LIGHT EMITTING ELEMENT KYULUX, INC. (JP) 2023-06-29 US disclosed
US-20230209847-A1 ORGANIC LIGHT EMITTING ELEMENT KYULUX, INC. (JP) 2023-06-29 US disclosed
US-20230119624-A1 COMPOSITION, FILM, ORGANIC LIGHT EMITTING ELEMENT, METHOD FOR PROVIDING LIGHT EMITTING COMPOSITION, AND PROGRAM KYULUX, INC. (JP) 2023-04-20 US disclosed
US-11335872-B2 Organic light-emitting device KYULUX, INC. (JP) 2022-05-17 US disclosed
US-20220123249-A1 ORGANIC LIGHT EMITTING ELEMENT KYULUX, INC. (JP) 2022-04-21 US disclosed
US-20210234113-A1 ORGANIC LIGHT-EMITTING DEVICE KYULUX, INC. (JP) 2021-07-29 US disclosed
US-20210074927-A1 ORGANIC ELECTROLUMINESCENT DEVICE KYULUX, INC. (JP) 2021-03-11 US disclosed
US-10862047-B2 Organic electroluminescent device KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2020-12-08 US disclosed
US-10658596-B2 2020-05-19 US disclosed
US-20160190478-A1 ORGANIC ELECTROLUMINESCENT DEVICE KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2016-06-30 US disclosed
US-20160190478-A1 ORGANIC ELECTROLUMINESCENT DEVICE KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230119624-A1 COMPOSITION, FILM, ORGANIC LIGHT EMITTING ELEMENT, METHOD FOR PROVIDING LIGHT EMITTING COMPOSITION, AND PROGRAM SOS1, MLLT1, ESYT2 PLCG2 1603/4885CSNK2A2 2603/4885CSNK2B 3667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.